$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$1.02B
Market Cap
-
P/E Ratio
-11.66
EPS
$42.39
52 Week High
$5.66
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing innovative oral small molecule therapies for oncology and inflammatory diseases. Utilizing a proprietary drug discovery platform that targets crucial immune regulatory pathways, RAPT is advancing a compelling pipeline designed to meet significant unmet medical needs in the realm of personalized medicine. The company's strategic focus on clinical excellence positions it to deliver transformative therapeutic options, with the potential to substantially improve patient outcomes and redefine standards in immunology.
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
ARTV
IREN
KVUE
CLSK
MARA
PLTD
ORCL
APLD
SNAP
DNN
TLRY
NFLX
T
WULF
BTBT
RGTI
RKLB
VZ
PLTR
BAC
UBER
NIO
RIG
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
MSTR
RR
HBAN
MSFT
VALE
CMG
CLYM
IONQ
NCLH
BMY
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
ARTV
IREN
KVUE
CLSK
MARA
PLTD
ORCL
APLD
SNAP
DNN
TLRY
NFLX
T
WULF
BTBT
RGTI
RKLB
VZ
PLTR
BAC
UBER
NIO
RIG
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
MSTR
RR
HBAN
MSFT
VALE
CMG
CLYM
IONQ
NCLH
BMY